India and US child vaccine schedules, side by side

Document: table dated 17 Mar 2026.

The schedule is headed "National Immunisation Schedule" and described as the prescribed schedule under the UIP for pregnant women, and infants and children; the Japanese Encephalitis vaccine is given to those living in endemic districts only.

• At birth the schedule lists BCG, OPV-0 dose and the hepatitis B birth dose
• At 6 weeks the schedule lists OPV-1, Pentavalent-1, Rotavirus Vaccine (RVV)-1, fractional dose of IPV (fIPV)-1 and Pneumococcal Conjugate Vaccine (PCV)-1
• At 10 weeks the schedule lists OPV-2, Pentavalent-2 and RVV-2
• At 14 weeks the schedule lists OPV-3, Pentavalent-3, fIPV-2, RVV-3 and PCV-2
• At 9-12 months the schedule lists Measles & Rubella (MR)-1, JE-1 (endemic districts only, per the document’s note) and PCV-Booster
• At 16-24 months the schedule lists MR-2, JE-2 (endemic districts only, per the document’s note), DPT-Booster-1 and OPV-Booster
• At 5-6 years the schedule lists DPT-Booster-2
• At 10 years and at 16 years the schedule lists Td (tetanus and adult diphtheria)

Source: static.pib.gov.in

Document: cdc.gov schedule page headed “Addendum updated July 2, 2025”; the rows quoted here are selected visits, from birth to the 4 to 6 years visit, and the page also carries older ages.

• At birth, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 1st dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page. (The page's other bar types are not listed here.)
• At 1 month, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 2nd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page. (The page's other bar types are not listed here.)
• At 2 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 2nd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page; Rotavirus: 1st dose; DTaP (diphtheria, tetanus, whooping cough): 1st dose; Hib: 1st dose; Pneumococcal conjugate: 1st dose; Polio (IPV): 1st dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 4 months, the cdc.gov table marks as routine, risk-based or shared decision: RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page; Rotavirus: 2nd dose; DTaP (diphtheria, tetanus, whooping cough): 2nd dose; Hib: 2nd dose; Pneumococcal conjugate: 2nd dose; Polio (IPV): 2nd dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 6 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page (only part of the bar is this category; see the page); RSV antibody: certain high-risk groups (only part of the bar is this category; see the page); Rotavirus: see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 3rd dose; Hib: see the notes on the page; Pneumococcal conjugate: 3rd dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): certain high-risk groups, see the notes on the page; Hepatitis A: certain high-risk groups, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 12 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; Hib: 3rd or 4th dose, see the notes on the page; Pneumococcal conjugate: 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 1st dose; Chickenpox (varicella): 1st dose; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 15 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 4th dose; Hib: 3rd or 4th dose, see the notes on the page; Pneumococcal conjugate: 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 1st dose; Chickenpox (varicella): 1st dose; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 18 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 4 to 6 years, the cdc.gov table marks as routine, risk-based or shared decision: DTaP (diphtheria, tetanus, whooping cough): 5th dose; Hib: certain high-risk groups (only part of the bar is this category; see the page); Pneumococcal conjugate: certain high-risk groups (only part of the bar is this category; see the page); Polio (IPV): 4th dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 2nd dose; Chickenpox (varicella): 2nd dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)

Source: cdc.gov